Lab901 Raises $4M in Equity Funding | GenomeWeb

NEW YORK (GenomeWeb News) – Scottish DNA analysis firm Lab901 has raised £2.4 million ($4 million) in equity funding from a group of UK investors, the company said today.

Lab901 plans to use the financing to expand international sales of its ScreenTape analysis platform and to continue to develop its products.

The new funding came from Archangel Informal Investment, Alliance Trust Equity Partners, Scottish Enterprise, Foresight 3 VCT, and TriCapital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.